UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors

Not Applicable

Completed

Conditions: Fatigue

Interventions: Behavioral: Open-label placebo intervention

First Posted Date: 2015-08-14

Last Posted Date: 2021-09-24

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 74

Registration Number: NCT02522988

Locations: 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

Phase 1

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: Letrozole
Drug: Everolimus
Drug: TRC105

First Posted Date: 2015-08-11

Last Posted Date: 2024-12-27

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 15

Registration Number: NCT02520063

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Influence of Ambient Temperature on Office Behaviors

Not Applicable

Completed

Conditions: Obesity

Interventions: Other: thermostat

First Posted Date: 2015-07-23

Last Posted Date: 2015-11-10

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 25

Registration Number: NCT02507310

Locations: 🇺🇸
University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, United States

ENABLE CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Behavioral: Usual HF Care
Behavioral: Behavioral Support

First Posted Date: 2015-07-22

Last Posted Date: 2022-01-18

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 573

Registration Number: NCT02505425

Locations: 🇺🇸
Birmingham Veterans Affairs Medical Center (BVAMC), Birmingham, Alabama, United States
🇺🇸
University of Alabama at Birmingham, School of Nursing, Dept. Acute, Chronic and Continuing Care, Birmingham, Alabama, United States

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease

Phase 2

Completed

Conditions: Chronic Kidney Disease
Albuminuria

Interventions: Drug: Spironolactone
Drug: Amiloride

First Posted Date: 2015-07-14

Last Posted Date: 2022-12-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 21

Registration Number: NCT02497300

Locations: 🇺🇸
Hypertension Research Clinic at UAB, Birmingham, Alabama, United States

Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders

Completed

Conditions: Movement Disorders

First Posted Date: 2015-07-02

Last Posted Date: 2018-05-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 21

Registration Number: NCT02488837

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Improving Weight Loss Maintenance Through Alternative Schedules of Treatment

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: variable interval schedule
Behavioral: self-directed treatment

First Posted Date: 2015-07-01

Last Posted Date: 2015-07-01

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 108

Registration Number: NCT02487121

A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)

Completed

Conditions: Cystic Fibrosis

Interventions: Other: Observational

First Posted Date: 2015-06-22

Last Posted Date: 2020-05-20

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 452

Registration Number: NCT02477319

Locations: 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
Hershey Medical Center; Penn State Children's Hospital, Hershey, Pennsylvania, United States
🇺🇸
Froedtert Hospital, Milwaukee, Wisconsin, United States

and more 35 locations

Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders

Completed

Conditions: Esophageal Diseases

First Posted Date: 2015-06-19

Last Posted Date: 2018-03-08

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 18

Registration Number: NCT02476513

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT

Not Applicable

Completed

Conditions: Affect
Caffeine
Cognitive Ability, General
Mood

Interventions: Drug: Placebo
Drug: Caffeine

First Posted Date: 2015-06-03

Last Posted Date: 2017-07-12

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 205

Registration Number: NCT02461693

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy